Stocks › MPLT
MapLight Therapeutics MPLT
US equityMarket cap rank #3724
$6.93 +$0.71 (+11.41%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $7.60 +9.67%
Open$6.24
Prev close$6.22
Day range$6.06 – $6.93
Volume502.0K
Market cap$385.14M
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q2, ended Jun 2026
Revenue$0.00
Operating profit-$63.55M-107.2% YoY
Net profit-$60.19M-101.7% YoY
Diluted EPS-$1.32-83.2% YoY
Free cash flow-$44.89M-31.9% YoY
Operating cash flow-$44.87M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Return on equity-445.2%
Return on assets-101.6%
Return on invested capital-428.4%
Current ratio16.52
Liabilities / assets5.4%
Cash & investments$304.73M
Total debt$755,000.00
Net cash (debt)$303.97M
Income statement
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Operating Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expense | $63.55M | $64.50M | $169.08M | $83.38M | $31.50M |
| Selling and Admin Expenses | $10.11M | $10.82M | $30.73M | $18.75M | $4.40M |
| -General & Admin Expense | $10.11M | $10.82M | $30.73M | $18.75M | $4.40M |
| Research & Development | $53.44M | $53.68M | $138.35M | $64.62M | $27.09M |
| Operating Profit | -$63.55M | -$64.50M | -$169.08M | -$83.38M | -$31.50M |
| Net Non-Operating Interest Income (Expense) | $2.35M | $2.47M | $5.52M | $2.47M | $1.55M |
| Non-Operating Interest Income | $2.35M | $2.47M | $5.52M | $2.47M | $1.55M |
| Other Income (Expense) | $1.01M | $1.36M | $2.41M | $1.36M | $531,000.00 |
| Other Non-Operating Income (Expenses) | $1.01M | $1.36M | $2.41M | $1.36M | $531,000.00 |
| Pretax Profit | -$60.19M | -$60.67M | -$161.15M | -$79.55M | -$29.42M |
| Net Profit | -$60.19M | -$60.67M | -$161.15M | -$79.55M | -$29.42M |
| Profit from Continuing Operations | -$60.19M | -$60.67M | -$161.15M | -$79.55M | -$29.42M |
| Net Income to Parent Company | -$60.19M | -$60.67M | -$161.15M | -$79.55M | -$29.42M |
| Net Income to Common Stockholders | -$60.19M | -$60.67M | -$161.15M | -$79.55M | -$29.42M |
| Basic EPS | -$1.32 | -$1.34 | -$18.56 | -$2.47 | -$0.71 |
| Diluted EPS | -$1.32 | -$1.34 | -$18.56 | -$2.47 | -$0.71 |
| Total Revenue as Reported | – | $0.00 | $0.00 | $0.00 | $0.00 |
| Earnings from Equity Interest | – | – | $0.00 | $0.00 | $0.00 |
Balance sheet
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Assets | $368.35M | $418.79M | $479.51M | $479.51M | $257.22M |
| Total Current Assets | $318.79M | $327.23M | $324.67M | $324.67M | $245.31M |
| Cash and Cash Equivalents & Short-Term Investments | $304.73M | $310.11M | $305.10M | $305.10M | $227.17M |
| -Cash and Cash Equivalents | $71.63M | $55.71M | $46.73M | $46.73M | $64.15M |
| -Short Term Investments | $233.09M | $254.41M | $258.37M | $258.37M | $163.02M |
| Other Current Assets | $14.06M | $17.12M | $19.57M | $19.57M | $18.14M |
| Total Non-Current Assets | $49.56M | $91.56M | $154.84M | $154.84M | $11.92M |
| Net PPE | $2.50M | $6.23M | $6.58M | $6.58M | $6.57M |
| -Gross PPE | $2.50M | $6.23M | $9.22M | $9.22M | $9.07M |
| Investments and Advances | $46.62M | $85.09M | $147.99M | $147.99M | $0.00 |
| -Available for Sale Securities | $46.62M | – | $147.99M | $147.99M | – |
| Other Non-Current Assets | $448,000.00 | $243,000.00 | $266,000.00 | $266,000.00 | $5.35M |
| Total Liabilities | $20.05M | $18.95M | $21.14M | $21.14M | $23.71M |
| Total Current Liabilities | $19.29M | $14.28M | $16.23M | $16.23M | $18.56M |
| Payables | $2.05M | $3.19M | $3.29M | $3.29M | $2.45M |
| -Accounts Payable | $2.05M | $3.19M | $3.29M | $3.29M | $2.45M |
| Current Accrued Expenses | $11.14M | $7.96M | $5.89M | $5.89M | $10.05M |
| Short-Term Debt and Capital Lease Obligation | $1.23M | $920,000.00 | $891,000.00 | $891,000.00 | $862,000.00 |
| -Current Capital Lease Obligation | $1.23M | $920,000.00 | $891,000.00 | $891,000.00 | $862,000.00 |
| Total Non-Current Liabilities | $755,000.00 | $4.67M | $4.91M | $4.91M | $5.14M |
| Long Term Debt and Capital Lease Obligation | $755,000.00 | $4.67M | $4.91M | $4.91M | $5.14M |
| -Long Term Capital Lease Obligation | $755,000.00 | $4.67M | $4.91M | $4.91M | $5.14M |
| Total Equity | $348.30M | $399.83M | $458.37M | $458.37M | $233.52M |
| Stockholders' Equity | $348.30M | $399.83M | $458.37M | $458.37M | $233.52M |
| Capital Stock | $5,000.00 | $5,000.00 | $5,000.00 | $5,000.00 | $507.69M |
| -Common Stock | $5,000.00 | $5,000.00 | $5,000.00 | $5,000.00 | $0.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $507.69M |
| Additional Paid-In Capital | $830.62M | $821.90M | $819.12M | $819.12M | $6.75M |
| Retained Earnings | -$481.38M | -$421.19M | -$360.52M | -$360.52M | -$280.97M |
| Gains/Losses Not Affecting Retained Earnings | -$944,000.00 | -$883,000.00 | -$228,000.00 | -$228,000.00 | $46,000.00 |
| -Accumulated Depreciation | – | – | -$2.64M | -$2.64M | -$2.50M |
| Current Deferred Liabilities | – | – | $0.00 | $0.00 | $1.21M |
Cash flow
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$44.87M | -$51.18M | -$138.14M | -$46.83M | -$31.79M |
| Net cash flow from continuing operations | -$44.87M | -$51.18M | -$138.14M | -$46.83M | -$31.79M |
| Net Income from Continuing Operations | -$60.19M | -$60.67M | -$161.15M | -$79.55M | -$29.42M |
| Gain/Loss from Continuing Operations | $0.00 | $4,000.00 | $7,000.00 | $0.00 | – |
| Depreciation & Depletion & Amortization | $147,000.00 | $162,000.00 | $578,000.00 | $140,000.00 | $136,000.00 |
| Other Non-Cash Items | $217,000.00 | $229,000.00 | $1.36M | $222,000.00 | $217,000.00 |
| Change in Working Capital | $7.33M | $273,000.00 | -$12.84M | -$1.72M | -$2.39M |
| -Change in Prepaid Assets | $2.85M | $2.48M | -$13.10M | -$2.33M | -$3.91M |
| -Change in Payables and Accrued Expense | $4.72M | -$1.99M | $4.28M | $2.02M | $2.91M |
| -Change in Other Current Liabilities | -$230,000.00 | -$211,000.00 | -$777,000.00 | -$204,000.00 | -$199,000.00 |
| Net cash flow from investing | $60.70M | $67.01M | -$323.21M | -$242.55M | -$135.59M |
| Net Cash Flow from Continuing Investing Activities | $60.70M | $67.01M | -$323.21M | -$242.55M | -$135.59M |
| Net PPE Purchase and Sale | -$22,000.00 | -$24,000.00 | -$473,000.00 | -$376,000.00 | -$31,000.00 |
| Net Investment Purchase and Sale | $60.73M | $67.03M | -$322.73M | -$242.18M | -$135.56M |
| Financing Cash Flow | $92,000.00 | -$6.85M | $469.82M | $271.97M | $198.06M |
| Net Cash Flow from Continuing Financing Activities | $92,000.00 | -$6.85M | $469.82M | $271.97M | $198.06M |
| Proceeds from Stock Option Exercised | $92,000.00 | $651,000.00 | $285,000.00 | $173,000.00 | $104,000.00 |
| Net Other Financing Charges | $0.00 | -$7.50M | -$5.02M | -$3.89M | -$916,000.00 |
| Ending Cash Balance | $71.84M | $55.91M | $46.94M | $46.94M | $64.35M |
| Net Change in Cash | $15.93M | $8.98M | $8.48M | -$17.42M | $30.68M |
| Beginning Cash Balance | $55.91M | $46.94M | $38.46M | $64.35M | $33.67M |
| Free Cash Flow | -$44.89M | -$51.20M | -$138.61M | -$47.21M | -$31.82M |
| -Change In Other Working Capital | – | – | -$3.24M | -$1.21M | -$1.20M |
| Net Preferred Stock Issuance | – | – | $474.56M | $275.69M | – |
No comments yet — be the first to weigh in on MPLT.
Sign in to join the discussion.